TytoCare raises additional $50M in Series D funding to let patients get 24/7 medical exams with a doctor, from the comfort of their homes

TytoCare, a mobile health platform that allows anyone to perform a self physical examination, and remote diagnosis, has raised an additional $50 million in Series D funding. The funding will allow TytoCare to continue to expand the availability of its full-stack telehealth and remote examination platform throughout the U.S., Europe, and Asia, as well as to make further inroads into the global healthcare payer market.

The funding comes on the heels of TytoCare raising $50M in April 2020, making for $100M raised over the last 10 months. Doubling down on its previous investment, Insight Partners led the extension with participation from new growth investors Tiger Global Management and Qumra Capital and existing investors Qualcomm Ventures LLC, Olive Tree Ventures, and Shenzhen Capital Group Company, bringing the company’s total funding to $155M to date.

Founded in 2012 by Dedi Gilad and Ofer Tzadik with a vision to put health in the hands of the consumer, TytoCare is the creator of the healthcare industry’s first all-in-one modular device and examination platform for AI-powered, on-demand, remote medical exams. TytoCare has FDA and CE clearances and has partnered with over 100 major health systems, health plans, and strategic partners in the U.S., Europe, Asia, and Israel.

TytoCare’s solutions are designed to replicate a facetious clinician visit and include a modular examination tool for examining the heart, lungs, skin, throat, ears, and body temperature; a complete telehealth platform for sharing exam data, conducting live video exams, and scheduling visits; a cloud-based data repository with analytics; and built-in guidance technology and machine learning algorithms to ensure accuracy and ease of use.

With increasing demands for its solutions, TytoCare also plans to use the funding to introduce new advanced product capabilities including AI and machine learning-based home diagnostics solutions and other patented technologies, following its recently launched AI-powered diagnostic support solution.

“TytoCare was on a strong growth trajectory long before COVID-19, and last year we experienced even more immense growth amidst surging demand,” said Dedi Gilad, Co-Founder and CEO of TytoCare. “The pandemic significantly accelerated telehealth awareness, adoption, and utilization worldwide, and current advances in AI-powered home-based clinical diagnoses are making virtual care even more personalized and effective for a wider population, as well as more use cases. This new funding is a strong vote of confidence in our solution and enables us to deliver comprehensive remote care to more patients and cutting-edge telehealth solutions to our partners faster.”

TytoCare brings its partners unique ROI and experiences double-digit telehealth utilization, over 5X higher than standard virtual care solutions – both before and during the COVID-19 pandemic. In the wake of the pandemic, hospitals, insurers, and health systems around the world are further expanding their use of TytoCare’s telehealth solution to enable the best quality remote primary care, chronic care, remote monitoring, and more.

“TytoCare sets itself apart in the telehealth market by providing patients, clinicians, and healthcare organizations worldwide with a unique end-to-end solution that goes far beyond the average video visit, with clinic-quality examinations and AI-powered diagnostic capabilities,” said Jeff Horing, Co-Founder and Managing Director, Insight Partners. “We are thrilled to be investing further in TytoCare and to continue to work with the company as it scales its solution and leads the pack with innovative advances in virtual care.”

To date, TytoCare has partnered with over 150 leading health organizations and insurers worldwide, with more than 6,000 clinicians currently using the telehealth solution. In 2020 alone, the company performed over 650,000 telehealth examinations globally.

“We are excited to add TytoCare to our portfolio of outstanding growth companies,” said Erez Shachar, Managing Partner at Qumra Capital. “Tyto’s innovative technology and solutions take telemedicine to the next level, enabling remote care with clinical data clinicians can trust, benefitting patients and clinicians’ experience alike. We are proud to have the opportunity to take part in their journey as they continue to revolutionize the global healthcare industry.”